---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-048036"
form_type: "8-K"
ticker: "MTNB"
cik: "0001582554"
company_name: "Matinas BioPharma Holdings, Inc."
filed_at: "2024-11-27T23:59:59+00:00"
generated_at: "2026-05-29T14:15:08.760642+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Kathryn Penkus Corzo resigns from Matinas BioPharma board effective Nov 22, 2024

## Summary
- Director Kathryn Penkus Corzo resigned from Board effective Nov 22, 2024, citing other professional obligations.
- Resignation not due to any material disagreement or change in company direction.
- She also resigned from Compensation and Nominating and Corporate Governance Committees.

## SEC filing metadata
- accession: 0001493152-24-048036
- form_type: 8-K
- ticker: MTNB
- cik: 0001582554
- company_name: Matinas BioPharma Holdings, Inc.
- filed_at: 2024-11-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582554/000149315224048036/0001493152-24-048036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582554/000149315224048036/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-048036
- JSON: https://secwatch.observer/filing/0001493152-24-048036.json
- Plain text: https://secwatch.observer/filing/0001493152-24-048036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.